CDC IXIS Innovation
investment firm
About
CDC IXIS Innovation
- Paris,Ile-de-France,France
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
6
2
CDC IXIS Innovation has made 6 investments. Their most recent investment was on
Jul 21, 2004, when NewStar Financial raised $450M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 21, 2004
NewStar Financial
|
Debt Financing | $450M | Finance | Yes |
|
Jul 8, 2004
OneAccess
|
Series C | €7.50M | Manufacturing | Yes |
|
Mar 5, 2003
NEMOPTIC
|
Series C | $12M | Consumer | — |
|
Dec 5, 2002
Catalyst Bioscience
|
Series Unknown | $46M | Biotechnology | — |
|
Nov 5, 2002
Kuros Biosciences
|
Series A | €7M | Biopharma | — |
Exits
CDC IXIS Innovation has had 4 exits. CDC IXIS Innovation most notable exits include OneAccess , Kuros Biosciences
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Oct 4, 2017 | OneAccess | M&A | Manufacturing | Detail |
| Jan 22, 2016 | Kuros Biosciences | IPO | Biopharma | Detail |
| Dec 15, 2006 | NewStar Financial | M&A | Finance | Detail |
| Apr 21, 2006 | Catalyst Bioscience | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
